A patient is receiving irinotecan as part of his chemotherapy regimen. After receiving the drug
Options:
A) The patient should avoid all physical activity to prevent side effects.
B) The patient should discontinue other medications to avoid interactions with irinotecan.
C) The patient should be monitored for potential side effects and adverse reactions.
D) The patient should increase fluid intake to enhance the effectiveness of irinotecan.
